Your browser doesn't support javascript.
loading
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.
Park, Yoon Sun; Kim, Joseph; Ryu, Yea Seong; Moon, Jai-Hee; Shin, Yu Jin; Kim, Jeong Hee; Hong, Seung-Woo; Jung, Soo-A; Lee, Seul; Kim, Seung-Mi; Lee, Dae Hee; Kim, Do Yeon; Yun, Hyeseon; You, Ji-Eun; Yoon, Dong Il; Kim, Chul Hee; Koh, Dong-In; Jin, Dong-Hoon.
Afiliação
  • Park YS; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Kim J; Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Ryu YS; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Moon JH; Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Shin YJ; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Kim JH; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Hong SW; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Jung SA; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Lee S; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Kim SM; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Lee DH; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Kim DY; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Yun H; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • You JE; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Yoon DI; Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kim CH; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Koh DI; Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Jin DH; Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
Cancer Biol Ther ; 24(1): 2246208, 2023 12 31.
Article em En | MEDLINE | ID: mdl-37621144
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article